Vanda Pharmaceuticals (VNDA) Amortizatization of Intangibles (2011 - 2012)
Vanda Pharmaceuticals (VNDA) reported Amortizatization of Intangibles of -$117000.0 for Q1 2012, up 62.86% on a YoY basis from -$71842.1 in Q2 2011, and up 62.86% sequentially from -$315000.0 in Q1 2011.
Vanda Pharmaceuticals (VNDA) Amortizatization of Intangibles (2011 - 2012) Analysis & Trends
Vanda Pharmaceuticals (VNDA) has 2 years of Amortizatization of Intangibles data on file, last reported at -$117000.0 in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Vanda Pharmaceuticals | 310.98 Mn | 108.67 Mn | 48.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | -117,000.00 |
| Mar 31, 2012 | -117,000.00 |
| Mar 31, 2011 | -315,000.00 |
| Mar 31, 2011 | -315,000.00 |